Identifies high-alert medication risks with ISMP guidelines and safety barriers. Use when reviewing high-risk medications, implementing safety checks, or preventing medication errors.
Identifies high-alert medication risks with ISMP guidelines and safety barriers to prevent medication errors across the prescribing, dispensing, and administration continuum.
Medication errors affect approximately 1.5 million people annually in the United States and cause over 7,000 deaths per year. The Institute for Safe Medication Practices (ISMP) maintains a list of high-alert medications that bear a heightened risk of causing significant patient harm when used in error. These include anticoagulants, insulins, opioids, neuromuscular blocking agents, concentrated electrolytes, and chemotherapy agents.
The Joint Commission National Patient Safety Goals require healthcare organizations to implement specific safeguards for high-alert medications. CMS Conditions of Participation mandate prospective drug utilization review (DUR) for every prescription. Pharmacists serve as the principal medication safety officers in healthcare systems, responsible for error prevention, detection, reporting, and system redesign. A structured medication safety review process—incorporating ISMP high-alert lists, tall-man lettering conventions, independent double-check protocols, and root cause analysis—is essential for meeting accreditation standards and reducing preventable harm.
Screen against the ISMP High-Alert Medication List for acute care settings:
ISMP High-Alert Categories:
For each high-alert medication identified, evaluate common error-prone conditions:
Prescribing errors:
Dispensing errors:
Administration errors:
Assess whether the following ISMP-recommended safeguards are in place:
| Safety Barrier | Expected Standard | Assessment Method |
|---|---|---|
| Independent double-check | Required for high-alert IV medications | Observe workflow, check policy compliance |
| CPOE dose range alerts | Hard stops for lethal dose ranges | Review alert configuration in EHR |
| Smart pump guardrails | Programmed limits matching approved concentrations | Audit pump library compliance |
| Tall-man lettering | Applied to all ISMP LASA pairs | Check pharmacy labels, EHR display |
| Barcode medication administration (BCMA) | Scan rate >95% for high-alert medications | Pull BCMA compliance reports |
| Auxiliary warnings | Applied to look-alike/sound-alike pairs | Inspect storage and labeling |
| Standardized concentrations | Single concentration for high-alert IV drips | Review IV admixture protocols |
| Limit access | Neuromuscular blockers segregated with warning labels | Inspect ADC and OR storage |
| Patient education | Verbal + written counseling for high-alert discharge meds | Review discharge process |
If reviewing a medication error or near-miss:
Structure the deliverable: